results from the cartitude-2 trial
Published 3 years ago • 110 plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
2:01
an update on cohort c from the cartitude-2 trial
-
4:40
cartitude-2 trial update and management of neurotoxicities
-
2:33
latest results from the cartitude-2 trial of cilta-cel in progressive multiple myeloma
-
0:48
updates and correlative results from the manifest-2 trial
-
2:44
second interim analysis of the emn02 trial
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
1:21
an update on cartitude-2: cilta-cel in patients with multiple myeloma in second line
-
8:16
results from cartitude-4: cilta-cel for lenalidomide-refractory multiple myeloma
-
21:38
drawing the line: the rationale behind blood tube collection order
-
5:17
the evolving role of autologous transplantation in multiple myeloma
-
4:24
how do we define cure for multiple myeloma?
-
9:57
quadruplet therapies for treating mm: the current evidence and the findings of a phase ii trial
-
1:24
updates on dreamm-2
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:46
guadecitabine in higher-risk mds/cmml: a phase ii trial
-
1:11
advances that have been made in the molecular characterization of multiple myeloma
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
1:03
insights into the cartitude-6 trial: rationale and design
-
0:41
isct in bringing together the scientific community
-
2:12
the impact of setd2 loss on cml progression
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv